Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic value of long non-coding RNA MALAT1 in hepatocellular carcinoma: A study based on multi-omics analysis and RT-PCR validation
Xiaoli Liao, Junming Chen, DongCheng Luo, et al.
Pathology & Oncology Research (2023) Vol. 28
Open Access | Times Cited: 20

Showing 20 citing articles:

Effects of DNA, RNA, and Protein Methylation on the Regulation of Ferroptosis
X R Wang, Xianghai Kong, Xin Feng, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 11, pp. 3558-3575
Open Access | Times Cited: 28
Ferroptosis and hepatocellular carcinoma: the emerging role of lncRNAs
Haoran Chen, Zhongyu Han, Junyan Su, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
Yulai Zeng, Shuyu Hu, Yi Luo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2365-2365
Open Access | Times Cited: 18
Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy
Beibei Liu, Ling Liu, Yang Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Epigenetic and Post-Translational Modifications in Ferroptosis Regulation and Hepatocellular Carcinoma: New Frontiers in Therapeutic Targeting
Soheil Bolandi, Samaneh Dodge, Zahra Zahed, et al.
Pathology - Research and Practice (2025), pp. 155991-155991
Closed Access
The MALAT1-breast cancer interplay: insights and implications
Muhammad Tufail
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 8, pp. 665-678
Closed Access | Times Cited: 10
Long Noncoding RNAs MALAT1 and HOTTIP Act as Serum Biomarkers for Hepatocellular Carcinoma
Han Bao, Yutian Jiang, Ning Wang, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 3
Noncoding RNAs in cancer ferroptosis: From biology to clinical opportunity
Chan Shan, Yan Liang, Kun Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115053-115053
Open Access | Times Cited: 7
Evaluation of the clinical significance of long non-coding RNA MALAT1 genetic variants in human lung adenocarcinoma
Shu‐Hui Lin, Jeng‐Wei Lu, Wang‐Ting Hsieh, et al.
Aging (2024) Vol. 16, Iss. 6, pp. 5740-5750
Open Access | Times Cited: 2
Triterpenes from Ganoderma lucidum inhibit hepatocellular carcinoma by regulating enhancer-associated lncRNA in vivo
Ruolin Zhao, Caiyun Zhang, Chenchen Tang, et al.
Journal of Ethnopharmacology (2024) Vol. 336, pp. 118706-118706
Closed Access | Times Cited: 2
Deciphering the nexus between long non-coding RNAs and endoplasmic reticulum stress in hepatocellular carcinoma: biomarker discovery and therapeutic horizons
Himanshi Goyal, Sachin Parwani, Jyotdeep Kaur
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Non-Coding RNAs as Potential Diagnostic/Prognostic Markers for Hepatocellular Carcinoma
Federica Tonon, Chiara Grassi, Domenico Tierno, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12235-12235
Open Access | Times Cited: 2
Role of ferroptosis and its non-coding RNA regulation in hepatocellular carcinoma
Lei Yang, Yu Guan, Zhanbing Liu
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Continued attention: The role of exosomal long non-coding RNAs in tumors over the past three years
Jiarui Cao, Bo Feng, Yanchao Xv, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113666-113666
Open Access | Times Cited: 1
Expression level of long non-coding RNA MALAT1, GAS5, DANCR and TUG1 in peripheral blood leukocytes of patients with non-alcoholic fatty liver disease
И. В. Курбатова, Alina Vasileva, Л. В. Топчиева, et al.
Experimental and Clinical Gastroenterology (2024), Iss. 10, pp. 160-167
Open Access
Detection and validity of long noncoding RNAs HOST2, HOTAIR, HOXA-AS2, and MALAT1 as biomarkers for hepatocellular carcinoma
Marwa Mohammed Ibrahim Mohammed Khalil, Randa Mohamed Seddik, Manal Monir Mansour, et al.
Human Gene (2024), pp. 201349-201349
Closed Access
Progress in research of ferroptosis in gastrointestinal tumors
Zhao-Chun Chi
Shijie huaren xiaohua zazhi (2024) Vol. 32, Iss. 10, pp. 699-715
Open Access
The ncRNA-AURKA Interaction in Hepatocellular Carcinoma: Insights into Oncogenic Pathways, Therapeutic Opportunities, and Future Challenges
Clarissa Joy C. Garcia, Luca Grisetti, Claudio Tiribelli, et al.
Life (2024) Vol. 14, Iss. 11, pp. 1430-1430
Open Access
Resveratrol promotes mitophagy via the MALAT1/miR-143-3p/RRM2 axis and suppresses cancer progression in hepatocellular carcinoma
Chunyan Feng, Chao Cai, Xinyi Shi, et al.
Journal of Integrative Medicine (2024)
Closed Access
MALAT1 and BCYRN1 lncRNAs expression in patients with breast cancer from Northwest Iran
Alireza Ahmadi, Amin Moqadami, Mohammad Khalaj‐Kondori, et al.
Human Gene (2024) Vol. 43, pp. 201370-201370
Closed Access
Page 1

Scroll to top